| __timestamp | Dr. Reddy's Laboratories Limited | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 2613100000 |
| Thursday, January 1, 2015 | 62786000000 | 2891500000 |
| Friday, January 1, 2016 | 62427000000 | 3228800000 |
| Sunday, January 1, 2017 | 62453000000 | 2966700000 |
| Monday, January 1, 2018 | 65724000000 | 2900200000 |
| Tuesday, January 1, 2019 | 70421000000 | 3064100000 |
| Wednesday, January 1, 2020 | 80591000000 | 3248100000 |
| Friday, January 1, 2021 | 86645000000 | 2722500000 |
| Saturday, January 1, 2022 | 100551000000 | 2996200000 |
| Sunday, January 1, 2023 | 42907000000 | 2975200000 |
| Monday, January 1, 2024 | 115557000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Dr. Reddy's Laboratories Limited and Perrigo Company plc, two prominent players, showcase intriguing trends in their cost of revenue from 2014 to 2024. Dr. Reddy's Laboratories, based in India, has seen a significant increase in its cost of revenue, peaking in 2024 with a staggering 115% rise from its 2014 figures. This growth reflects the company's expanding global footprint and investment in research and development. In contrast, Perrigo Company, headquartered in Ireland, maintains a more stable cost structure, with fluctuations of less than 25% over the same period. This stability highlights Perrigo's focus on efficiency and cost management. Notably, 2023 data for Dr. Reddy's shows a dip, possibly indicating strategic shifts or market challenges. Missing data for 2024 suggests ongoing developments worth monitoring.
Cost Insights: Breaking Down Neurocrine Biosciences, Inc. and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Grifols, S.A.
Dr. Reddy's Laboratories Limited vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Grifols, S.A. and Perrigo Company plc
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Perrigo Company plc's Expenses
Analyzing Cost of Revenue: Perrigo Company plc and Supernus Pharmaceuticals, Inc.
Cost of Revenue Trends: Perrigo Company plc vs Celldex Therapeutics, Inc.